Here, we spoke to experts about the anti-aging benefits of growth factor serums. Shop the 11 best growth factor serums now.
The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement ...
The U.S. Food and Drug Administration has approved Eli Lilly's Inluriyo (imlunestrant), an oral estrogen receptor antagonist, ...
Phase 1 study to progress to the next dose level of 75mCi in patients with HER2+ advanced solid tumors, instead of the ...
Ensem Therapeutics, Inc. (ENSEM) today announced the U.S. Food and Drug Administration (FDA) granted Fast Track designation ...
New findings reveal zongertinib's effectiveness against brain metastases in HER2-mutant non–small cell lung cancer, offering hope for better treatment options. Human epidermal growth factor receptor 2 ...
Astellas Pharma Canada Inc. is proud to announce that VYLOY® (zolbetuximab) is now funded by the Ontario Drug Benefit Program under the New Drug Funding Program and in Quebec through the Liste des ...
HealthDay on MSN
Elderly Patients Benefit From Screening Mammography
Patients with breast cancer diagnosed at 80 years of age or older who received screening mammography present with ...
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of ARV-102, a PROTAC LRRK2 Degrader, in Healthy Participants Date & Time : Oct.
Eli Lilly secured FDA approval for breast cancer drug Inluriyo and EU clearance for Alzheimer's therapy Kisunla following ...
Hypoxia, or low oxygen in the body, is common in solid tumors. Now, researchers have identified that an RNA molecule, EUDAL, ...
Theranostics announced that it has received a positive recommendation from the Data Safety and Monitoring Committee to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback